Home patients with diabetes trial a continuous glucose monitor
Part of Hormones & metabolism clinical trials.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are enrolled in Mayo’s Advanced Care at Home and will stay there at least 72 hours
- You have type 1 or type 2 diabetes
- You use insulin under the skin (either injections or an insulin pump)
- You can understand the study and sign the consent form
- You are not currently using a continuous glucose monitor (CGM) for insulin dosing or glucose checks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using your own continuous glucose monitor (CGM) while you are in the hospital (but not the ICU) can help better manage your blood sugar levels. If you already use a CGM at home and are admitted for at least two days, you may be able to keep using it during your stay.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This study tests if using a continuous glucose monitor (a small sensor that checks blood sugar without finger pricks) helps people with type 2 diabetes who are on insulin and have trouble accessing care. It's for patients in the New Orleans area with Medicaid, free care, or no insurance.
This study asks people with diabetes to use a continuous glucose monitor (a small device that tracks blood sugar automatically) and share their thoughts about it. Researchers want to understand what features matter most to patients and how well the device works in real life.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.